Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Kedudukan dalam Saham #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Harga Saham
$0.2219522
Disegerakkan terakhir: 2025-09-11
Modal Pasaran
$1.10B
Perubahan (1 hari)
0.04%
Perubahan (1 tahun)
0.17%
Negara
CN
Perdagangan Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Pendapatan untuk Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Pendapatan pada Sep 2024 TTM: $-246.31M
Menurut laporan kewangan terkini Hubei Biocause Pharmaceutical Co., Ltd., pendapatan semasa syarikat ialah $-246.31M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $32.59M, penurunan berbanding pendapatan pada tahun 2021 yang berjumlah $53.98M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Hubei Biocause Pharmaceutical Co., Ltd. dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-246.31M -6.66%
2023 $-263.90M -909.84%
2022 $32.59M -39.64%
2021 $53.98M -75.67%
2020 $221.88M -57.48%
2019 $521.80M 36.14%
2018 $383.27M -8.47%
2017 $418.73M -15.31%
2016 $494.40M 859.98%
2015 $51.50M 192.79%
2014 $17.59M -182.99%
2013 $-21.20M -981.31%
2012 $2.40M -112.99%
2011 $-18.51M -493.30%
2010 $4.71M -45.74%
2009 $8.67M 709.23%
2008 $1.07M -93.04%
2007 $15.40M 107.42%
2006 $7.42M 610.69%
2005 $1.04M 72.62%
2004 $605.05K -110.58%
2003 $-5.72M -392.76%
2002 $1.95M -72.00%
2001 $6.97M 18.03%
2000 $5.91M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$43.81B -17,885.82%
CN
$9.54B -3,973.90%
HK
- -
CA
- -
TW
- -
US